Cargando…

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action

BACKGROUND: Hepatitis C virus (HCV) transmission in the European Union, European Economic Area and United Kingdom is driven by injecting drug use (IDU), which contributes to the high burden of chronic infection among people in prisons. This study aimed to describe the context, epidemiology and respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakitanda, Aya Olivia, Montanari, Linda, Tavoschi, Lara, Mozalevskis, Antons, Duffell, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650151/ https://www.ncbi.nlm.nih.gov/pubmed/33167912 http://dx.doi.org/10.1186/s12889-020-09515-6

Ejemplares similares

Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2023)

Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis
por: Nakitanda, Aya Olivia, et al.
Publicado: (2021)

Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
por: Seyler, T, et al.
Publicado: (2022)

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2022)

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
por: Falla, Abby May, et al.
Publicado: (2018)

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
por: Mason, Lauren MK, et al.
Publicado: (2019)

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review
por: Mason, Lauren M. K., et al.
Publicado: (2019)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
por: Ahmad, Amena A., et al.
Publicado: (2018)

Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
por: HOFSTRAAT, S. H. I., et al.
Publicado: (2017)

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions
por: Duffell, Erika F, et al.
Publicado: (2017)

Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021
por: Singh, Jasleen, et al.
Publicado: (2022)

Hepatitis A notifications in the EU/EEA, 2010–2019: what can we learn from case reporting to the European Surveillance System?
por: Severi, Ettore, et al.
Publicado: (2023)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
por: Falla, A. M., et al.
Publicado: (2018)

Prevalence of injected drug use and access to OAT in prison: survey in 7 EU countries, 2014-2018
por: Mazzilli, S, et al.
Publicado: (2022)

6.M. Workshop: Models of care in prison: addressing infectious diseases during and after the pandemic in EU/EEA
Publicado: (2022)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
por: Bivegete, Sandra, et al.
Publicado: (2023)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
por: Greenaway, Christina, et al.
Publicado: (2018)

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
por: Desai, S, et al.
Publicado: (2019)

Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020
por: Van Heuverswyn, Jasper, et al.
Publicado: (2023)

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review
por: Pottie, Kevin, et al.
Publicado: (2018)

Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018
por: Benkő, Ria, et al.
Publicado: (2022)

A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region
por: Moonen, Chrissy P. B., et al.
Publicado: (2023)

Investigation of an international outbreak of multidrug-resistant monophasic Salmonella Typhimurium associated with chocolate products, EU/EEA and United Kingdom, February to April 2022
por: Larkin, Lesley, et al.
Publicado: (2022)

Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017
por: Spiteri, G, et al.
Publicado: (2017)

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021
por: Angeloni, Giorgia, et al.
Publicado: (2023)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
por: Duffell, Erika, et al.
Publicado: (2021)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last Decade
por: Montalti, Marco, et al.
Publicado: (2020)

Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020
por: Högberg, Liselotte Diaz, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Comparison, by Country, of the Uptake of COVID-19 Vaccination by Health Care Workers in the EU/EEA
por: McGlacken, T, et al.
Publicado: (2023)

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
por: Croxford, S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qo2s44dtfhgh76u2anqasdip13